Answers are grounded in this paper and cite their sources.
Direct comparative data in septuagenarians remain limited; leaves open optimal bioprosthetic strategy for longer life expectancy.
Background: The expansion of transcatheter aortic valve implantation (TAVI) into younger, lower-risk patients has raised concerns regarding long-term durability, while the advent of sutureless aortic valve (AV) prostheses underscores the need for comparative evidence to define the optimal bioprosthetic strategy in patients with longer life expectancy. Given the paucity of direct comparative data in septuagenarians, we sought to assess the relative clinical and longitudinal hemodynamic outcomes of these two treatment strategies. Methods: We retrospectively analyzed 210 patients aged 70–79 years with severe aortic stenosis (AS) who underwent either sutureless AV replacement (SAVR) (n=94) or TAVI (n=116) between 2015 and 2021. Longitudinal echocardiographic and clinical outcomes were evaluated. Hemodynamic trajectories were analyzed using mixed-effects models, and clinical outcomes were compared using Cox and Fine-Gray competing-risk models. Propensity score (PS)-based inverse probability of treatment weighting (IPTW) was applied to mitigate selection bias. Results: Rates of early adverse events, including mortality, permanent pacemaker (PPM) implantation, and myocardial infarction (MI), were comparable between the SAVR and TAVI groups. During a median follow-up duration of 36.7 months [interquartile range (IQR), 17.8–52.3 months], SAVR demonstrated more favorable longitudinal hemodynamic performance, with divergent transvalvular pressure gradient trajectories compared with TAVI (group-by-time interaction, P=0.007). Paravalvular leakage (PVL; ≥ moderate) occurred exclusively in the TAVI group (12.7% at 5 years). Although overall survival did not differ between the groups, fewer strokes occurred after SAVR than after TAVI [2 vs. 7 events; adjusted hazard ratio (HR), 5.47; 95% confidence interval (CI): 1.46–20.46; P=0.01]. The risk of other valve-related adverse events did not differ significantly. Conclusions: In septuagenarian patients with severe AS, SAVR was associated with more favorable longitudinal hemodynamics and fewer observed strokes than TAVI, with comparable survival.
No takes yet. Share an insight, caveat, or question.
Pyo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: